3d
Hosted on MSNADHD drug changes likely to have unintended consequencesAnalysis: Dilemma is whether to shift burden of ADHD assessment and treatment to the community because specialist services ...
Strattera is prescribed to treat ADHD. Learn more about how long the drug takes to kick in and how long it lasts.
Qelbree is now the first ADHD treatment to meet the FDA's post-marketing requirement for lactation studies, following the 2019 guidance on Clinical Lactation Studies. Supernus believes that this ...
Supernus Pharmaceuticals' FDA approval for ONAPGO in Parkinson's Disease offers optimism despite past challenges, with a ...
4d
News Medical on MSNCommon Treatment for Binge Eating Disorder Shows Mixed ResultsPatients taking a commonly used stimulant for the treatment of binge eating disorder experienced mixed results, according to ...
HealthDay on MSN11d
Adderall shortage sparks scramble for ADHD medication alternativesAdderall shortages have prompted doctors to switch kids with attention-deficit/hyperactivity disorder to other forms of ...
Magdalena aiming to submit Investigational New Drug (IND) application in 2025 to the FDA for a next-generation psychoactive prescription drug candidate for potential mental health indications such as ...
Granules India receives FDA approval for generic ADHD drug, expanding portfolio and reinforcing presence in treatment space.
Dexamphetamine – a restricted stimulant drug used to treat narcolepsy and Attention Deficient Hyperactivity Disorder (ADHD) – might not be as addictive as previously thought, new research from the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results